Corteva (NYSE:CTVA) Updates FY 2026 Earnings Guidance

Corteva (NYSE:CTVA) updated its FY 2026 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 3.600-3.800 for the period, compared to the consensus earnings per share estimate of 3.740. The company issued revenue guidance of -, compared to the consensus revenue estimate of $18.3 billion.

Corteva Stock Performance

CTVA traded down $10.36 during trading on Friday, hitting $78.98. 10,704,389 shares of the company traded hands, compared to its average volume of 4,004,083. The firm has a market cap of $52.83 billion, a P/E ratio of 46.46, a price-to-earnings-growth ratio of 2.74 and a beta of 0.56. The stock’s fifty day moving average is $82.16 and its 200 day moving average is $79.55. The company has a quick ratio of 1.03, a current ratio of 1.47 and a debt-to-equity ratio of 0.07. Corteva has a one year low of $60.53 and a one year high of $90.97.

Corteva (NYSE:CTVA) last announced its quarterly earnings data on Thursday, July 30th. The company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.24 by $0.06. The business had revenue of $6.38 billion for the quarter, compared to analyst estimates of $6.60 billion. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The company’s revenue for the quarter was down 1.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. As a group, equities analysts predict that Corteva will post 3.76 EPS for the current fiscal year.

Corteva Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Investors of record on Tuesday, September 1st will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Tuesday, September 1st. Corteva’s payout ratio is 42.35%.

Analyst Ratings Changes

Several equities research analysts have commented on the stock. Bank of America upped their price objective on shares of Corteva from $90.00 to $96.00 and gave the company a “buy” rating in a report on Monday, July 20th. Oppenheimer upped their price target on shares of Corteva from $89.00 to $95.00 and gave the company an “outperform” rating in a research note on Thursday, July 23rd. Royal Bank Of Canada lifted their price objective on shares of Corteva from $97.00 to $103.00 and gave the company an “outperform” rating in a research note on Tuesday, July 21st. Mizuho boosted their target price on shares of Corteva from $96.00 to $97.00 and gave the company an “outperform” rating in a report on Tuesday, July 14th. Finally, Wells Fargo & Company increased their target price on Corteva from $85.00 to $90.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 21st. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and eight have given a Hold rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $90.19.

Corteva News Summary

Here are the key news stories impacting Corteva this week:

• Positive Sentiment: Corteva reported second-quarter adjusted EPS of $2.30, exceeding the $2.24 analyst consensus and rising from $2.20 a year earlier. Seed pricing, productivity improvements, demand for newer genetics and traits, and growth in Crop Protection products supported margins. Reuters earnings report
• Positive Sentiment: The company raised its fiscal 2026 EPS outlook to $3.60-$3.80, reflecting strong first-half performance, operating improvements and growth platforms. Management also said it remains on track for the planned October 1 Vylor spin-off, a potential catalyst for improved business focus and valuation. Corteva first-half results and outlook
• Positive Sentiment: Analyst commentary remains broadly constructive: Corteva has outperformed the broader market and agriculture-focused ETFs, while brokerages maintain a consensus “Moderate Buy” rating. Momentum-focused analysis also highlights the company’s improving execution and fundamentals. Brokerage consensus rating
• Neutral Sentiment: Despite the earnings beat and higher guidance, one analysis argues that much of Corteva’s improved execution is already reflected in the stock, leaving limited upside unless earnings growth accelerates. Corteva valuation analysis
• Negative Sentiment: Second-quarter revenue was $6.38 billion, below the $6.60 billion consensus and down 1.2% year over year. The sales miss, together with competitive pricing pressure, appears to be the main reason the stock moved lower despite the profit beat and raised outlook. Corteva second-quarter earnings summary

Institutional Investors Weigh In On Corteva

Several hedge funds have recently bought and sold shares of CTVA. Invesco Ltd. raised its position in shares of Corteva by 16.7% during the 4th quarter. Invesco Ltd. now owns 11,404,960 shares of the company’s stock valued at $764,474,000 after buying an additional 1,630,712 shares in the last quarter. Axxcess Wealth Management LLC lifted its stake in Corteva by 1.2% during the fourth quarter. Axxcess Wealth Management LLC now owns 31,120 shares of the company’s stock worth $2,086,000 after purchasing an additional 355 shares during the last quarter. Corient Private Wealth LLC boosted its holdings in shares of Corteva by 4.8% in the 4th quarter. Corient Private Wealth LLC now owns 203,950 shares of the company’s stock worth $13,422,000 after purchasing an additional 9,388 shares in the last quarter. Ameriflex Group Inc. increased its position in shares of Corteva by 14,875.0% during the 4th quarter. Ameriflex Group Inc. now owns 599 shares of the company’s stock valued at $40,000 after purchasing an additional 595 shares during the last quarter. Finally, Mercer Global Advisors Inc. ADV raised its holdings in shares of Corteva by 3.8% during the 4th quarter. Mercer Global Advisors Inc. ADV now owns 71,499 shares of the company’s stock valued at $4,793,000 after buying an additional 2,620 shares in the last quarter. 81.54% of the stock is currently owned by institutional investors.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.